HLA
ALDR

Hamilton Lane Advisors’s Alder Biopharmaceuticals ALDR Stock Holding History

Hamilton Lane Advisors’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-22,359
Closed -$1.18M – 65
2015
Q2 		$1.18M Buy
+22,359
New +$813K 0.45% 38

Other funds holding ALDR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Hamilton Lane Advisors's ALDR Position: Q3 2015 in Review

Hamilton Lane Advisors sold out of Alder Biopharmaceuticals (ALDR) in Q3 2015, closing a stake of 22,359 shares — an estimated $1.18M sold.

Hamilton Lane Advisors first reported a position in ALDR in Q2 2015 and held it in 1 quarter. The position peaked at $1.18M in Q2 2015. 140 funds tracked by Wall St. Rank hold ALDR as of Q3 2015.

  • Hamilton Lane Advisors reported no remaining Alder Biopharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Hamilton Lane Advisors sold 22,359 Alder Biopharmaceuticals shares in Q3 2015, an estimated $1.18M.
  • Hamilton Lane Advisors first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 1 quarter.
  • Hamilton Lane Advisors's Alder Biopharmaceuticals position peaked at $1.18M in Q2 2015.
  • 140 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2015.

Based on Hamilton Lane Advisors's 13F filing for Q3 2015, filed 19 Oct 2015.